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Abstract 
Several Gram-negative pathogenic bacteria have evolved a complex protein secretion 
system termed the Type Three Secretion System (TTSS) to deliver bacterial effector 
proteins into host-cells that then modulate host-cellular functions. These bacterial devices 
are evolutionarily related to the flagellar apparatus. Although the TTSSs are substantially 
conserved among different species, the effector molecules they deliver are species-
unique. There exist three human pathogenic Yersiniae. Yersinia enterocolitica and 
Yersinia pseudotuberculosis cause self-limiting gastro-enteric diseases and infect 
mesenteric lymph nodes, while Yersinia pestis is transmitted by fleas and can be 
aerosolized, causing the lethal disease known as plague (also known as Black Death). 
The TTSS is composed of over 20 proteins making up the injectisome (inserted directly 
into the host-cell), in addition to translocator, regulator, and modulator proteins, as well 
as chaperones for several effector proteins. Today, plague is still a health concern due to 
the ability of Y. pestis to be aerosolized. No effective vaccines are currently available to 
the public. However, research is being implemented to create a vaccine that can be 
widely used. The purpose of this paper is to update the state of the Yersiniae TTSSs by 
providing a review of recently published primary articles. 
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Yersiniae Virulence Factors: Type III Secretion System 
 Of three human pathogenic Yersiniae, Y. enterocolitica and Y. pseudotuberculosis 
enter their hosts via the oral-fecal route of infection and are self-limiting enteric 
pathogens, which infect the mesenteric lymph nodes (14). In contrast, Y. pestis is 
transmitted by fleabite or via the aerosol route and infect regional lymph nodes or lungs 
leading to the lethal disease known as plague (14). 
 Y. pestis is thought to have evolved from Y. pseudotuberculosis relatively recently 
(27). Molecular clock estimates, based on mutational differences, place Y. pestis’ 
emergence as recently as 9,000 to 40,000 years ago. In comparing Y. pestis and Y. 
pseudotuberculosis, Y. pestis has two additional plasmids and has lost some chromosomal 
genes by deletion or inactivation. These differences enable Y. pestis to survive in its 
vector, the flea, and account for Y. pestis’ unique route of infection (27).  
 Common to all three pathogenic Yersiniae is the presence of type III secretion 
system (TTSS) (14, 8). The TTSS is encoded on an approximately 70-kb virulence 
plasmid termed pYVE or pCD1 (8). The TTSS functions to inject bacterial effector 
proteins directly into the host-cell cytoplasm and has thus been referred to as an 
injectisome (8). This system can also be found in several Gram-negative bacteria, and 
although the systems are highly conserved, the effector molecules delivered into targeted 
host-cells are unique for each bacterial species (8).  
 The TTSS functions by means of a secretion apparatus composed of 20-25 
different Yersinia secretion proteins (Yscs) (8, 18, 23). In fact, all 25 Yscs are required 
for a fully functioning secretion apparatus (14). It is believed that these injectisomes are 
environmental sensory receptors that sense the 37 C, low intracellular calcium 
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concentration of the host-cell, which induces the expression of the effector proteins from 
TTSS operons. This response is known as the low-calcium response (14). Interestingly, 
Ysc proteins that comprise the TTSS’s injectisome are homologous to flagellar proteins 
and therefore are thought to have evolved divergently from the flagellar proteins (Figure 
1).  
 Regulation and function of the Yersiniae TTSSs have been extensively studied. A 
detailed description of the TTSS and the Gram-negative bacteria who posses it was 
published in 1998 by Hueck (14). A more recent description of the Yersinia Outer 
Proteins (Yops) was published in 2005 by Viboud and Bliska (36). The aim of this paper 
is to update the state of the Yersiniae TTSSs. 
 There are 13 Yops, which are secreted by the TTSS injectisome. These proteins 
are grouped roughly into the following categories: (i) translocatory proteins involved in 
the translocation process, (ii) regulatory proteins, and (iii) effector proteins with direct 
anti-host functions. Interestingly, three of the effector proteins with direct anti-host 
functions, YopH, YpkA (YopO in Y. enterocolitica), and YopM, which are translocated 
into the host cytoplasm, are homologous to eukaryotic proteins and are thought to have 
been acquired from the eukaryotic host-cells. For example, YopH is a protein with 
tyrosine phosphatase activity and is homologous to the eukaryotic protein tyrosine 
phosphatase (PTPase) (11). The Yersiniae utilize YopH to dephosphorylate several 
macrophage proteins, thereby evading phagocytosis (14).  
Plague continues to be a determent to our society. Between 1987 and 2001, 36, 
876 cases of plague with 2,847 deaths were reported to the World Health Organization 
(WHO) (27). Closer to home, in 1992, there was an outbreak in which a plethora of 
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chipmunks were found dead in the four corners region of the United States: New Mexico, 
Arizona, Utah, and Colorado. Another reason the plague continues to be a health concern 
is because of Y. pestis’ unique ability to be aerosolized (communicated via respiratory 
droplets) and potentially be weaponized by bioterrorists (27).  While much has been 
accomplished in determining Y. pestis’ mechanism of action in causing plague, more still 
needs to be discovered to produce an adequate vaccine.  
 At present, no effective plague vaccines are available. Those previously 
developed and used in humans confer low levels of protection, have numerous side 
effects, and require frequent boosting to develop immunity (27). However, LcrV is an 
effector protein translocated along with other Yops by the TTSS and is now being 
targeted as a vaccine candidate (26). 
Injectisome: The TTSS needle 
 The TTSS employs a needle-like apparatus, termed the injectisome, to translocate 
effector proteins directly into the cytosol of a targeted host-cell (8). The injectisome is 
composed of about 25 Yscs and uses three translocator Yops, YopB, YopD and LcrV, to 
form a pore in the host-cell for the translocation of the effector Yops across the target cell 
membrane (8, 18, 23) (Refer to Yersinia outer proteins section below). Injectisomes 
consist of a basal body spanning both the inner and outer bacterial membranes and a 
needle (23). 
 Recently, many of the proteins that make up the injectisome have been shown to 
be homologous to flagellar proteins (14). A possible explanation for the evolution of the 
TTSS needle is that it divergently evolved from the basal body of the flagellar apparatus 
(14). After its evolution, several Gram-negative bacteria could have acquired the system 
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by horizontal genetic transfer. Although the secretion apparatus is highly conserved 
among many Gram-negative bacteria, the effector molecules that they deliver are unique 
to each bacterial species. Therefore, the needle complex may have divergently evolved 
from the flagellar proteins, whereas the effector molecules were not. 
A comparison of the flagellar protein FliN and injectisome protein Ysc Q showed 
that FliN carries a carboxy-terminal domain of 60 amino acids that is homologous to a 
respectively located domain in the members of the YscQ family (14). It was also shown 
that FliF shares a domain with YscJ (14) (Figure 1). 
 
Structural homologs suggest common evolutionary heritage. 
 
(a). FliN_Y. pestis:     61-123 
      YscQ_Y. pestis:    236-298 
 
FliN_Y. pestis             I P V K L S V E L G R T K M T  I   K E L L R L S Q G S V V S L D G L A G  E P L D I  L  I  N G Y L I  A Q   
YscQ_Y. pestis           LP V Q V S F E V G R Q I  L  D W H T L T S  L E P G S  L I  D L T T  P V D G E V R L L A N G R L L G H   
 
FliN_Y pestis  G E V V V V A D K Y G V R I 
YscQ_Y. pestis  G R L V E  I  Q G R  L G V R  I 
 
(b). FliF Y. pt:      56-242 
       YscJ Y. pt:     23-213 
 
FliF Y. pt  L Y S N L S D R D G G D I  V T Q  L T Q L N I  P Y  –  R F A D N G G A -  -  L L  I  P A E K V H E T R L   
YscJ Y. pt  L Y T G I  S Q K E G N E M L A L  L R Q E G L S A D K E P  D K D G K I K L L V E E  S D V A Q A I  D  
  
 
FliF Y. pt  R L A Q Q G L P  K G G A V G F E  L L D Q E  K F G I S Q F S E Q I  -  -  -   N Y Q R A L E G E L S R T I   
YscJ Y. pt  I  L K R K  G Y P H E  S F  S  T L Q D V F P  K D G L I S S  P I  E E L A R L N Y A K A Q E  -  -  I S R T L  
 
FliF Y. pt  G T L G P V L N V R V H  L A M P K P S L F V  R E Q K  S P  T A S V T L A L Q P G R A L D – D G Q I  
YscJ Y. pt  S  E I  D G V L V A R V H V V L  P E E Q – N N K G K K G V A A S A S V F I  K H A A D I Q F  D T Y I  
 
FliF Y. pt   N A I V Y M V S  S S V A G L P P G N V T V V D Q T G R L L T Q S D S A G R D L N A S Q L K F T S  E 
YscJ Y. pt   P  Q I K Q L  V N N S I  E G L A Y D R I  S V  I  L V P S V D V R Q S S H L  P R N T S  I  L S  I Q  V S E E 
 
Figure 1. The amino acid sequences for these proteins were obtained from the National Center for Biotechnology Information (NCBI) 
database and compared using Basic Local Alignment Search Tool (BLAST) (7, 24). Dark blue indicates identities. Aqua indicates 
amino acid similarities. (a)Analysis of FliN_Y. pestis flagellar motor switch protein and YscQ_Y. pestis Yop protein translocation 
protein Q reveals 33% identity and 53% amino acid similarity. (b) Analysis of FliF_Y. pseudotuberculosis (Y. pt) flagellar motor 
switch protein and YscJ_Y. pt Yop protein translocation protein Q reveals 23% identity and 46% amino acid similarity.  
 
The end of the needle-like structure is made up of YscF, with YopN possibly 
acting as a “plug”(33). The role of LcrV, YscF, and YopN in the formation of the pore 
required by the injectisome to deliver the Yops in macrophages was tested by monitoring 
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the release of the low-molecular-weight fluorescent dye BCECF (2′, 7′-bis- (2-
carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester, 623 Da) and of the 
high-molecular-weight lactate dehydrogenase (LDH, 135 kDa). Bacteria producing 
normal Ysc injectisomes, including the YscF needle but no translocators, did not form 
pores, indicating that the needle is not sufficient by itself for pore formation. YopN might 
form a link between the needle and the pore, guiding the effectors (18). 
 In a more recent study, it was found that the length of the injectisome is 
genetically defined (2). The length of the needle is determined by YscP, which acts as a 
molecular ruler (3). It is found that a minimal needle length was required for efficient 
functioning of the Y. enterocolitica injectisome and the minimal needle length correlated 
with the length of the major adhesin at the bacterial surface. The needle may be required 
for triggering type III secretion, suggesting that needle length may have evolved to match 
specific structures at both the bacterial and host-cell surfaces (22). YscP is also secreted 
and was found to be required for Yop secretion by a systematic deletion analysis where 
the specific region required for Yop secretion (between residues 405 and 500) was 
accurately localized (2).  
 YscU, also a key component of the TTSS injectisome, undergoes auto-cleavage of 
an N-terminal transmembrane domain and a long cytoplasmic C-terminal domain at a 
NPTH site (32). A yscUN263A mutant makes needles without the LcrV tip complex, 
essential to pore formation, and could not form translocation pores. The yscUN263A 
mutant was also shown to export less amounts of YscP (the molecular ruler) and 
consequently, made longer needles (32).  
  It was recently shown by electron microscopy (EM) analysis that the tip of 
7
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needles that protrude from the bacterial surface contained a distinct structure caused by 
LcrV bound to YscF (19). This unique localization of LcrV may explain its crucial role in 
the translocation process and its efficacy as the main protective antigen against plague as 
a vaccine candidate.  
Yersinia Outer Proteins (Yops) 
 The Yops (toxic effector proteins) are encoded on several operons on the 
virulence plasmid, and their expression is induced after a temperature shift from 25ºC to 
37ºC, but at 27ºC in the presence of Ca
2+ 
the system remains repressed (14, 41). Normal 
growth of Y. pestis occurs at 25ºC to 27ºC (ambient temperature in flea gut). Eventually, 
this temperature shift and contact with the mammalian cell (low calcium), leads to the 
injection of the effector Yops from the bacterium into the host cell (41). 
 The Yops and other proteins secreted by Yersinia TTSS have been roughly 
grouped into three categories: (i) translocatory proteins involved in the translocation 
process and pore formation (YopB, YopD, and LcrV), (ii) proteins with direct anti-host 
function and are translocated directly into the eukaryotic cytosol (YopH, YopM, YopE, 
YopT, and YopJ) (16), and (iii) regulatory proteins, which mediate cell contact (YopN 
and YopK) (14, 36) (Table 1). 
Table 1. Yops and Other Proteins Secreted by Yersinia TTSS (13, 15, 33) 
(i) Translocatory Proteins 
YopB, YopD, 
and LcrV Are involved in the translocation process and pore formation 
(ii) Proteins with direct anti-host function 
YopH Is a tyrosine protein phosphatase 
YopM Binds to -thrombin and blocks platelet activation 
YopE Directly polymerizes actin microfilaments 
YopT Is similar to YopE, YpkA/YopO are a serine/threonine protein kinases 
YopJ                                                         
Interferes with mammalian signaling pathways leading to the inhibition of phagocytosis, 
modulation of cytokine production, and induction of apoptosis 
(iii) Regulator Proteins 
YopN Is surface exposed and involved in the low-calcium response 
YopK Seems to regulate the amount of effector Yops translocated 
8
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YopB, YopD, and LcrV: Translocators 
 YopB and YopD are encoded in the lcrGVH-yopBD operon and their transcription 
is induced by temperature (37 C) and millimolar concentrations of calcium (low-calcium 
level, mimicking the internal host-cell environment) (14).  It has been shown that YopB, 
YopD (14), and LcrV are translocator proteins (33, 36). While these proteins are involved 
in translocation, they are not actually translocated into the targeted host-cells. It has also 
been suggested that these proteins make up the “translocation channel” in the host-cell 
membrane (pore-formation) mainly because of their hydrophobic domains. However, 
LcrV is the exception being a dimer in solution (36). The hydrophobic domains found in 
YopB and YopD, suggested that they are probably transmembrane proteins. Interestingly, 
YopB has been shown to independently disrupt artificial membranes, whereas YopD 
cannot. YopB may achieve this by virtue of its two hydrophobic regions (residues 166 to 
188 and 228 to 250). Recently, YopB’s ability to disrupt membrane was characterized by 
altering the hydrophobic domains of YopB and then studying the change in the virulence 
of the mutant strain containing the altered YopB protein (30).  
 In the aforementioned experiment, a helix-disrupting double consecutive proline 
substitution in the center of the transmembrane domain of YopB proteins was 
constructed. Either both hydrophobic domains were disrupted or only one hydrophobic 
domain was disrupted. Y. pseudotuberculosis expressing the mutant proteins was used to 
infect macrophage or epithelial cells. As it turned out, YopB with two disrupted domains 
resulted in a non-functional protein, which was not secreted and the YopB with only one 
disrupted hydrophobic domain had partially disrupted function. Ultimately, all three 
9
Blanco: Yersiniae Virulence Factors: Type III Secretion System
Published by NSUWorks, 2008
Yersinia Virulence Factors 10 
functions of YopB, translocation, pore formation, and signaling, require these 
hydrophobic domains for insertion into the host-cell membrane (30).  
 The ability of YopB to insert into the host-cell membrane creating a channel 
along YopD explains how the injectisome can maintain contact with the host-cell without 
disrupting the integrity of the host-cell membrane. Furthermore, LcrV has also been 
found to form channels in lipid bilayers and is believed to be part of the pore-formation 
process making up the channel in which effector proteins are translocated (36). Also, it 
has been found that the interaction of YopB with the host-cell triggers a pro-
inflammatory signaling response in epithelial cells infected with y. pseudotuberculosis 
(35). In fact, it was recently suggested that YopB could potentially be used to enhance the 
immune response in eukaryotic cells (5).  
YopH, YopO (YpkA), YopE, YopT, YopM, YopJ (YopP): Effectors  
 The most pronounced effects by the TTSS involves the action of several effector 
Yops, such as YopE, YopH, YopO/YpkA, and YopT, which disrupt the target cell-
signaling network and cytoskeleton rearrangement by targeting monomeric GTPases of 
the Rho family (8, 41). YopH, YopO (YpkA in Y. pseudotuberculosis), YopE, YopM, 
and YopJ (YopP in Y. enterocolitica) are directly translocated into the host-cell 
cytoplasm by the TTSS. Interestingly, three of these effector proteins have been found to 
be homologous to eukaryotic proteins (Figure 2). 
YopH: A Tyrosine Protein Phosphatase 
 It is believed that several of these translocated effector Yops have been acquired 
from the host itself. The yersiniae are able to use these homologous host proteins, to their 
advantage. For example, YopH is a 468 amino acid long protein with tyrosine 
10
Mako: NSU Undergraduate Student Journal, Vol. 2 [2008], Art. 3
http://nsuworks.nova.edu/mako/vol2/iss1/3
Yersinia Virulence Factors 11 
phosphatase and its carboxy terminal is homologous to the eukaryotic protein tyrosine 
phosphatase (PTPase). In fact, YopH was shown to be the most active tyrosine 
phosphatase known (11). The Yersiniae utilize YopH to dephosphorylate several 
macrophage proteins contributing to their resistance to phagocytosis. One way in which 
YopH has been shown to evade phagocytosis has been by inhibiting the invasin 
interaction activated,  1 integrin pathway. YopH has two substrate recognition sites 
(11). The presence of two substrate recognition sites is believed to be the evidence for 
why this PTPase-like protein has evolved a highly complex mechanism to locate 
substrates in the complex environment of the host-cell (36). 
 In a recent study, the factors important for growth during lung infection were 
determined (9). Using a YopH mutant strain of Y. pseudotuberculosis, mice were infected 
intra-nasally and growth was monitored in lungs and systemic tissues. As it turned out, 
the YopH mutant failed to proliferate at wild-type levels four days after intranasal 
inoculation. This study concluded that YopH, together with YopB, was essential for 
development of a Y. pseudotuberculosis murine lung infection (9).   
YpkA/YopO: A Serine/Threonine Protein Kinase 
 YpkA (YopO in Y. enterocolitica), approximately 730 amino acids, is transcribed 
on an operon together with YopJ/YopP (14). YpkA has a serine/threonine kinase catalytic 
site on the N-terminal half of the protein that is homologous to the eukaryotic 
serine/threonine protein kinase (36). Like YopE and YopT, YpkA interacts with 
RhoGTPase and thereby disrupts the actin cytoskeleton of cultured cells to prevent 
phagocytosis (1). Because YpkA is weakly expressed, and the effector proteins, YopE 
and YopH, mask its activity, a mutant with the deletion of these other two effector 
11
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proteins has to be made in order to detect the activity of YpkA (14, 36, 39). It was 
recently shown that a Y. pseudotuberculosis YpkA mutant with a deletion of its kinase 
domain was greatly attenuated in a murine model of infection (39).   
YopE: A GTPase Activating Protein (GAP) 
 YopE, 219 amino acids, is highly conserved amongst all three pathogenic Yersiniae 
(14). YopE has been found to induce cytotoxic effects on host cells (4, 14, 36, 37). It was 
proposed that YopE exhibits GTPase-activating protein (GAP) activity towards Rac1, 
RhoA and Cdc42 and is essential for induction of the cytotoxic phenotype on HeLa cells 
(rounding, etc.) and virulence (38). Although it had been demonstrated that the 
cytotoxicity of YopE was due to its GAP activity toward the small GTP binding proteins, 
RhoA, Rac-1, and Cdc42, in vitro (1) there was no formal evidence for a direct 
interaction between YopE and any of these three RhoGTPases during an in-vivo 
infection. In an effort to understand the functional role of YopE in vivo, its GAP activity 
in infected eukaryotic cells was found to inactivate Rac1 as early as 5 minutes after 
infection. On the other hand, RhoA was downregulated approximately 30 minutes post 
infection and YopE had no apparent effect on the activation state of Cdc42 in infected 
cells. This study demonstrated that Cdc42 is not an in vivo target for YopE, and that 
YopE preferentially interacts with Rac1, and to a lesser extent with RhoA, within 
targeted host-cells (4). Ultimately, the major function of YopE is thought to be its 
contribution to the overall antiphagocytic activity of the Yersiniae TTSS (37).  
YopT: Like YopE, also Downregulates Rho GTPase  
 YopT, 322 amino acids, is not expressed by sero-type strains of Y. 
pseudotuberculosis and was therefore, the last effector protein identified in 2002 (8, 14). 
12
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In 2003, a yopE null (complete knock-out) Y. pseudotuberculosis mutant was found to be 
much more attenuated than the Y. enterocolitica yopE mutant. This was most likely due 
to Y. pseudotuberculosis lacking YopT. More importantly, RhoA modification was 
shown to be strictly dependent on YopT without the need of any additional effector Yops 
(18). More recently, YopE and YopT were shown to have some level of functional 
redundancy by sharing overlapping virulence functions (37). Observations such as the 
disruption of stress fibers, cell rounding, and inhibition of phagocytosis by YopE and 
YopT led to this assumption (36).  
 In order to explore this assumption, the contributions of YopE and YopT to the 
pathogenesis of Y. pseudotuberculosis were studied in a mouse infection and tissue 
culture infection model. A YopE
+
T
- 
strain and a YopE
+
T
+
 strain colonized spleens of 
mice at similar levels after four days of oral infection. This observation suggests that 
YopT is not required for virulence. In sharp contrast, spleen colonization by a YopE
-
T
-
 
strain was significantly reduced. However, a YopE
-
T
+
 strain colonized spleens at levels 
comparable to those of the YopE
+
T
-
 strain. These data suggest that YopT can promote 
virulence in the absence of YopE (37).  
 Furthermore, infection of HeLa cells with YopE
-
T
-
H
-
J
-
 strain expressing either 
YopE or YopT showed that YopE had a stronger antiphagocytic activity than YopT. This 
study concluded that YopE is a potent inhibitor of infection-induced signaling cascades, 
and YopT can only partially compensate for the loss of YopE (37), which explains why a 
Y. enterocolitica yopE mutant, still experiences attenuated virulence.  
YopM: Blocks Platelet Activation by Binding Thrombin 
 YopM, 376 amino acids, contains variable numbers of leucine rich repeat motifs 
13
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and is the only Yersiniae TTSS effector Yop that does not encode an enzymatic activity 
(36). YopM is homologous to the thrombin-binding domain of the  chain of human 
platelet surface glycoprotein Ib (GPIb ). This protein is also homologous to a portion of 
von Willebrand factor, which apart from its many functions, serves as a carrier of clotting 
factor VIII (14) (Figure 2). Purified YopM was shown to bind thrombin and to inhibit 
platelet aggregation in vitro (14). Although it is known that YopM plays an important 
role in pathogenesis, the significance of thrombin binding for Y. pestis pathogenesis is not 
clear (12). It is believed that YopM may compete with platelets for thrombin binding in 
vivo and that the resulting prevention of blood clot formation could enhance the 
dissemination of the bacteria throughout the body (14). Interestingly, YopM is 
translocated into the cytosol of the host-cell and has been shown to localize to the nucleus 
of the target cell (8), but it is not known how nuclear localization is related to the function 
of YopM (36). The most recent data indicated that YopM targets the innate immune 
system, as it was required for depletion of NK cells after intravenous infection of mice 
with Y. pestis (15). Studies in which gene regulation by YopM was examined, gave 
contradictory results as well as murine infection data (36). Figure 2 illustrates the 
alignment of y. pestis’ YopM with human platelet glycoprotein Ib  (GP-Ib ). 
Structural homologs suggest common evolutionary heritage. 
 
(a). GP-Ip :                43-132 
      YopM_Y. pestis:    273-353 
 
GP-Ip    P D L P K D T T  I  L H L S E N L L Y T F S L A T  L M P Y T R L T Q  L N L D R C E L T K L Q V 
YopM_Y. pestis  P E  L P Q S  L T F L D V S E N I  -   -  - F S G L  S E  L  P  – P N L Y Y L N A S S  N E I  R S L  -  - 
 
 
GP-Ip                D  G T  L P V L G T L D  L S H N Q L Q S L P L L G Q T L P A L T V L D V S F N R L T  S L  P 
YopM_Y. pestis  C  D  L P P  S L  E E L N V S N N K L  I  E L P A L P  -  -  -  P R L E R L  I  A S F N H L A E V P 
 
 
Figure 2. The amino acid sequences for YopM and GPIb  were obtained from the NCBI database and compared using BLAST (20). 
Dark blue indicates identities. Aqua indicates amino acid similarities. (a)Analysis of human platelet glycoprotein Ib  (GP- Ib ) and 
Y. pestis Yop protein translocation protein M reveals 36% identity and 50% amino acid similarity.  
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YopJ: A Cysteine Protease 
 YopJ (YopP in Y. enterocolitica), 264 amino acids, has been shown to induce 
apoptosis in cultured murine macrophages (21). More recently, YopJ was found to cause 
apoptosis by inhibiting the mitogen-activating protein kinase (MAPK) and nuclear factor-
B (NF- B) signaling pathways of the host-cell and blocking host proinflammatory 
response by suppressing cytokine production (36), and interfering with ubiquitination 
(tagging of proteins to be destroyed) (14). Yops counteract the MAPK and NF- B 
signaling pathways of the host-cell by acting like a protease by means of binding and 
blocking activation of the MAPK kinases and IKK (36, 42).  Because NF- B promotes 
cell survival, a recent study set out to determine whether inhibition of NF- B by YopJ 
was enough to cause apoptosis (42). In order to accomplish this, macrophages expressing 
NF- B inhibitors were infected with Y. pseudotuberculosis strains either expressing YopJ 
or not. As it turned out, the Y. pseudotuberculosis strains expressing YopJ were more 
effective in causing apoptosis than the strains that were not expressing YopJ, suggesting 
that deactivation of both NF- B and MAPK pathways are necessary for Yersinia to cause 
rapid apoptosis (42). YopJ has also been shown to be a deubiquitinating enzyme that 
negatively regulates signaling by removing ubiquitin moieties from critical proteins. In 
that regard, an in vitro assay demonstrated the deubiquitinating activity of purified YopJ 
(43).  
 When YopP was directly coupled to YopJ, YopP was secreted more readily than 
YopJ (41). Recently, a YopJ-deleted mutant strain of Y. pestis expressing YopP was 
shown to provide a better apoptotic potential. In J774A.1 cells (a BALB/c murine 
macrophage strain usually used for the production of monoclonal antibodies), RAW264.7 
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cells (a murine macrophage strain that does not demonstrate
 
the prostaglandin (PG)-
dependent autocrine regulation of tumor
 
necrosis factor- (TNF-) secretion observed in 
primary resident
 
peritoneal macrophages (RPMs)), and primary murine macrophages, 
better than even the most virulent strains of Y. pestis, EV76 and Kimberley 53 (35).  It 
has been proposed that perhaps Y. pestis expressed YopJ instead of YopP because in Y. 
pestis’ early stages of infection it propagates in macrophages, and, therefore, it is more 
advantageous for Y. pestis if these host-cells stay alive (41).  
 Still, the YopJ contribution to Y. pestis virulence is not clear. A recent study 
concluded that YopJ suppresses tumor necrosis factor  (TNF- ) induction and 
contributes to apoptosis of immune cells in the lymph node but is not a virulence factor in 
a rat model of bubonic plague (17). Following intra-dermal infection with a fully virulent 
Y. pestis strain or an isogenic yopJ mutant, it was determined that the deletion of yopJ 
resulted in a two-fold decrease in the number of apoptotic immune cells in the bubo, a 
swollen lymphnode, and a threefold increase in serum tumor necrosis factor  levels but 
did not result in decreased virulence, systemic spread, or colonization levels in the spleen 
and blood. Ultimately, the data suggest that YopJ is not essential for bubonic plague 
pathogenesis, but rather, the effects of YopJ appear to overlap and augment the 
immunomodulatory effects of other Y. pestis virulence factors (17).  
 More recently, YopJ was shown to exert its deleterious effect by catalyzing the 
acetylation of two serine residues in the activation loop of the MAP kinase kinase, 
MEK2, thereby preventing the phosphorylation of these serine residues required for 
activation of MEK2 and downstream signal propagation. YopJ has been shown to 
acetylate a threonine residue in the activation loop of both the  and  subunits of the 
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NF- B pathway kinase, IKK (21). In addition, YopJ was found to not only inhibit 
production of the inflammatory cytokine tumor necrosis factor  (TNF- ), but also was 
found to inhibit the anti-inflammatory cytokine, interleukin-10 (IL-10) expression (6). 
YopN and YopK: Regulator and Modulator 
YopN and YopK are considered to be regulatory proteins because they mediate 
cell contact and also have regulatory involvement (14). YopN is surface exposed and is 
involved in the low-calcium response (14). TTSS secretion channels shut in the presence 
of millimolar concentrations of Ca
2+
 found in mammalian blood (18). YopN mutants 
were found to secrete large quantities of Yops even in the presence of Ca
2+
. For this 
reason, YopN is thought to act as a “plug”. In the presence of an appropriate secretion 
signal (low calcium concentration), YopN is secreted into the supernatant by the Yersinia 
TTSS followed by the other effector Yops (18).  
 Unlike YopN, YopK seems to regulate the amount of effector Yops that are 
translocated by acting as a modulator (13). YopK is encoded outside the lcrG-lcrV-sycD-
yopBD operon, and its expression is also regulated by temperature and calcium levels. 
YopK is not translocated, but appears to be located in the vicinity of cell-associated 
bacteria during the infection process (14). YopK was shown to play a modulatory role in 
the translocation process when a YopK mutant expressed hypertranslocation (14).  
Other Virulence Associated Factors: PNPase 
 Recently, it has been found that the exoribonuclease, polynucleotide 
phosphorylase (PNPase) is required for the optimal function of the Yersiniae TTSS (29). 
HeLa cells were used to examine the cytotoxic effect of Y. pseudotuberculosis and Y. 
pestis pnp mutants by comparing mutant strain cytotoxicity to that of the wild-type 
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strains. The kinetics of the HeLa cell cytotoxicity induced by pnp strains appeared 
delayed, thereby indicating that the pnp strain had compromised TTSS activity (29). 
More importantly, it was also shown that complementing the mutant strains with the S1 
RNA-binding domain of PNPase could restore the optimal TTSS function. Furthermore, 
a murine infection using the above mentioned strains recapitulated attenuated virulence in 
the pnp strain (28).  
Chaperones 
 Yops are translocated through a narrow hollow hole in the injectisome in an 
unfolded state, suggesting that proteins may be secreted before acquiring their native 
conformations (40). Some of these translocated or secreted proteins have been shown to 
require small, usually acidic, accessory proteins with binding specificity towards each 
individual secreted protein that maintains them in an unfolded conformation required for 
passing through the needle (14, 40). These small chaperone proteins are required for 
presecretory stabilization (14). The TTSS chaperones appear to keep secreted proteins 
from prematurely interacting with translocatory proteins, fulfilling their role as 
bodyguards (their second name) (14).   
 Chaperones have been described for the effector proteins YopE, YopT, and 
YopH. SycE is the chaperone for YopE, SycT is the chaperone for YopT, and SycH is the 
chaperon for YopH (34). SycD is the chaperone for both YopB and YopD (10, 24, 35), 
while ScyN uses YscB (an injectisome protein) as a co-chaperone for secretion of YopN 
in Y. pestis (35). Recently, two crystal structures of YopN in complex with its 
heterodimeric secretion chaperone, SycN–YscB, and also the co-regulatory protein, 
TyeA, were solved. These two structures were combined to construct a theoretical model 
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of the YopN–SycN–YscB–TyeA complex (31). However, no chaperones had been 
described for YopO, YopP, YopQ (YopK in Y. pseudotuberculosis), and YopM.  More 
recently, though, it was shown that these proteins did not require the assumed chaperones 
(35).    
Infection still a problem 
 Bubonic plague is a lethal disease caused by Yersinia pestis. The Japanese 
weaponized Y. pestis from 1932 until the end of the Second World War when they used 
Y. pestis-flea bombs on civilians and prisoners (27). Instead of using the flea as a vector, 
some countries began to try aerosolizing Y. pestis. After 1969, the U.S. unilaterally 
ceased in the production of biological weapons. Although not proven, it is believed that 
the former Soviet Union created large facilities whose sole purposes were to find a way 
to deliver Y. pestis strains by aerosol (27).  
 The U.S. national laboratory response network detects biological terrorism agents 
such as Y. pestis. Once possible uses of biological weapons are found, they are referred to 
the Center for Disease Control (CDC) and the American Society for Microbiology to 
identify and confirm the Y. pestis strains (27). Streptomycin is traditionally regarded as 
the most affective treatment for Y. pestis, 1g (twice daily) for ten days and was the first 
antimicrobial shown to be affective against the pneumonic plague. Another drug that has 
been found to be affective is aminoglycosidegentamycin. Although very rare, it has been 
found that some strains of Y. pestis are antibiotic resistant, but luckily they have only 
been reported in Madagascar (27). Unfortunately, the plasmid responsible for the 
resistance has been reported to be self-transferrable to other bacteria (27).  
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Vaccine Production  
 Killed-whole-cell vaccines and live-attenuated vaccines have been created in the 
past, but have been found to be less than adequate. Not only do both vaccines only 
provide a short duration of protective immunity, but also the killed-whole-cell vaccine 
did not protect against primary pneumonic plague, while the live-attenuated vaccines 
maintained enough virulence to be unsuitable and excessively dangerous for public use 
(27). They offer low levels of protection, have numerous side effects, and require 
frequent immunization (26). 
 As a result, researchers are looking towards subunit vaccines as the answer. LcrV 
is an effecter protein translocated along with several Yops by the TTSS. This protein 
suppresses the host’s immune system response. A subunit vaccine in development is 
based on LcrV (also known as the (V) antigen). In a recent study, an adenovirus-based 
vaccine vector expressing the V-antigen was used to immunize mice. The experimental 
findings were that mice immunized with a single intramuscular dose of the vaccine were 
protected from a lethal intranasal challenge of Y. pestis (26). Therefore, hope for an 
effective mechanism whereby infection can be halted may be on the horizon. 
Conclusion 
 There are three human pathogenic Yersiniae, which share a common virulence 
factor termed the Type Three Secretion System present on an approximately 70-kb 
virulence plasmid. Many other Gram-negative bacteria possess this system, which allows 
them to transfer effector proteins directly into the host cell. The proteins that make up the 
apparatus “injected” into the host cell termed the injectisome are homologous in all the 
species that posses this system. However, the effector proteins are species-unique and are 
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believed to have been acquired from the hosts each species infect. There is still a health 
concern associated with Yersiniae especially with the plague-causing Y. pestis and its 
ability to be aerosolized, making it a potential bioterrorist weapon. Understanding the 
biology of the virulence factors of Yersiniae will allow for the development of novel 
preventative and therapeutic strategies to cope with Yersiniae infections.  
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